Muthana Al Abo
YOU?
Author Swipe
View article: Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 2
View article: Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 1
View article: Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 3
View article: Supplementary Video 3 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 3 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 3
View article: Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Contains Supplementary Figures 1-4, Supplementary Tables 1-2 and legends for Supplementary Videos 1-4
View article: Supplementary Video 3 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 3 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 3
View article: Supplementary Video 4 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 4 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 4
View article: Supplementary Video 1 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 1 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 1
View article: Supplementary Video 4 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 4 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 4
View article: Data from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Data from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Triple-negative breast cancers (TNBCs) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early stage localized TNBC, the rate of distant recurrence remains high, and long-term …
View article: Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Contains Supplementary Figures 1-4, Supplementary Tables 1-2 and legends for Supplementary Videos 1-4
View article: Supplementary Video 2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 2
View article: Supplementary Video 1 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 1 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 1
View article: Supplementary Video 2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 2
View article: Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 1
View article: Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Contains Supplementary Figures 1-4, Supplementary Tables 1-2 and legends for Supplementary Videos 1-4
View article: Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 2
View article: Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 3
View article: Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 1
View article: Data from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Data from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Triple-negative breast cancers (TNBC) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early-stage localized TNBC, the rate of distant recurrence remains high, and long-term s…
View article: Supplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 4
View article: Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 2
View article: Supplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 4
View article: Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 3
View article: Data from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Data from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Triple-negative breast cancers (TNBC) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early-stage localized TNBC, the rate of distant recurrence remains high, and long-term s…
View article: Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Contains Supplementary Figures 1-4, Supplementary Tables 1-2 and legends for Supplementary Videos 1-4
View article: Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Triple-negative breast cancers (TNBC) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early-stage localized TNBC, the rate of distant recurrence remains high, and long-term s…
View article: Ca<sup>2+</sup>/Calmodulin Dependent Protein Kinase Kinase-2 (CaMKK2) promotes Protein Kinase G (PKG)-dependent actin cytoskeletal assembly to increase tumor metastasis
Ca<sup>2+</sup>/Calmodulin Dependent Protein Kinase Kinase-2 (CaMKK2) promotes Protein Kinase G (PKG)-dependent actin cytoskeletal assembly to increase tumor metastasis Open
Triple-negative breast cancers (TNBCs) tend to become highly invasive early during cancer development. Despite some successes in the initial treatment of patients diagnosed with early-stage localized TNBC, the rate of metastatic recurrence…
View article: Data from TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors
Data from TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors Open
2'-C-cyano-2'-deoxy-1-β-d-arabino-pentofuranosylcytosine (CNDAC) is the active metabolite of the anticancer drug, sapacitabine. CNDAC is incorporated into the genome during DNA replication and subsequently undergoes β-elimination th…
View article: Supplementary Figure 1 from TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors
Supplementary Figure 1 from TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors Open
Schematic representation of the strategy used to knockout TDP1 by CRISPR/Cas9 in TSCER2 (A) or HCT116 (B) cells. RT-PCR of TDP1 mRNA in TSCER2 is shown (A).